Virotherapy treatment in clinics of Latvia
Virotherapy is a biological therapy, an innovative direction in the modern treatment of oncology. It is based on the treatment of malignant tumors by introducing an oncotropic and oncolytic virus into the patient’s body. As a rule, it is a safe intestinal tract virus that finds and attacks cancers. The developers of the methodology are Latvian scientists, therefore virotherapy in Latvia is developed better in comparison with other countries. And that is why an increasing number of patients are resorting to cancer treatment in Latvia.
Want to know how much the treatment costs?
Answer a few questions and get preliminary information about the cost of diagnosis and treatment!
Benefits of treating oncology with virotherapy
The main virotherapeutic agent in the treatment of oncology in Latvia is Rigvir. This drug allows to achieve a number of positive advantages:
- Especially effective in the treatment of diseases against which traditional methods of chemotherapy and radiation are ineffective (for example, skin cancer);
- The use of the drug is allowed ambulatory;
- Unlike traditional methods of treating oncology, the patient’s immunity is not suppressed, but rather it is activated;
- In some cases, almost 40% more effective than traditional therapy;
- In the absence of contraindications, it is well combined with other types of treatment, enhancing the effectiveness of therapeutic measures.
The greatest effect from the use of the drug is observed in the treatment of cancers of the gastrointestinal tract, urinary tract, and respiratory organs.
How does cancer treatment occur in the Latvian Virotherapy Center?
- All medical procedures are carried out according to the personal treatment plan developed by the attending physician, under the supervision of specialists;
- As a rule, the full course of treatment lasts for several years. Doctors divide it into stages lasting from 3 to 6 months. Further correction of the duration of therapy and doses of the drug is determined on the basis of intermediate analyzes, reflecting in dynamics the course of treatment;
- Although the use of Rigvir during treatment with traditional methods is not recommended, in the virotherapy clinic in Latvia after additional consultations, the attending physician may prescribe the use of the drug in the pauses between chemotherapy and radiation;
- Doctors of the Virotherapy Center in Latvia constantly monitor the state of the patient’s immunity over time, based on the test results;
- The effectiveness of virotherapy is determined immediately, the results of the blood test clearly show the increased activity of leukocytes. The effectiveness of the method as a whole, manifests itself much later, as, indeed, with traditional therapy.
The cost of virotherapy in Latvia
The cost of virotherapy in Latvia is determined by many factors, but, in general, is determined on the basis of the package of services chosen by the patient and the level of service. The price of virotherapy in Latvia varies, on average, from 790 EUR for the Basic package, to 5,100 EUR for the Premium package.
The cost of virotherapy in Latvia is determined by many factors, but, in general, is determined on the basis of the package of services chosen by the patient and the level of service. The price of virotherapy in Latvia varies, on average, from 790 EUR for the Basic package, to 5,100 EUR for the Premium package.
- “Basic” (790 EUR) includes the patient's stay in the clinic for one day, during which consultation by a specialist is made and a personal treatment plan is developed.
- “Standard” (from 1200 EUR) - stay in the clinic for 3 days. In addition to the services of the “Basic” package, it includes some tests with tracking in dynamics and nurse care.
- “Optimal” (2100 EUR) - services for hotel booking and transfer, additional research, and a diagnosis by at least three specialists have been added to the “Standard” one.
- Premium (5100 EUR) - a full range of medical services, including accommodation services, a personal car with a driver, translation services.
Violetta YanyshevskaAuthor and medical editor
